Citigroup Inc Arvinas, Inc. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Arvinas, Inc. stock. As of the latest transaction made, Citigroup Inc holds 58,264 shares of ARVN stock, worth $1.31 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

58,264

Previous 73,382 20.6%

Holding current value

$1.31 Million

Previous $1.95 Million 26.52%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$23.66 - $32.73 $357,691 - $494,812	-15,118 Reduced 20.6%	58,264 $1.44 Million
Q2 2024 Aug 12, 2024	BUY	$24.46 - $40.4 $1.37 Million - $2.27 Million	56,213 Added 327.41%	73,382 $1.95 Million
Q1 2024 May 10, 2024	SELL	$36.38 - $52.31 $4.42 Million - $6.35 Million	-121,487 Reduced 87.62%	17,169 $708,000
Q4 2023 Feb 09, 2024	BUY	$14.19 - $42.33 $1.9 Million - $5.67 Million	133,966 Added 2856.42%	138,656 $5.71 Million
Q3 2023 Nov 09, 2023	SELL	$19.64 - $28.21 $451,307 - $648,237	-22,979 Reduced 83.05%	4,690 $92,000
Q2 2023 Aug 10, 2023	BUY	$21.73 - $31.43 $448,268 - $648,369	20,629 Added 293.03%	27,669 $686,000
Q1 2023 May 11, 2023	BUY	$26.15 - $37.26 $19,246 - $27,423	736 Added 11.68%	7,040 $192,000
Q4 2022 Feb 09, 2023	SELL	$32.47 - $57.24 $78,479 - $138,349	-2,417 Reduced 27.71%	6,304 $215,000
Q3 2022 Nov 10, 2022	SELL	$41.87 - $57.99 $184,186 - $255,098	-4,399 Reduced 33.53%	8,721 $388,000
Q2 2022 Aug 10, 2022	BUY	$36.01 - $74.24 $135,613 - $279,587	3,766 Added 40.26%	13,120 $552,000
Q1 2022 May 12, 2022	SELL	$60.27 - $81.57 $389,344 - $526,942	-6,460 Reduced 40.85%	9,354 $629,000
Q4 2021 Feb 10, 2022	SELL	$65.85 - $96.21 $1.22 Million - $1.78 Million	-18,498 Reduced 53.91%	15,814 $1.3 Million
Q3 2021 Nov 10, 2021	BUY	$73.2 - $107.87 $2.51 Million - $3.7 Million	34,312 New	34,312 $2.82 Million

Others Institutions Holding ARVN

# of Institutions

229

Shares Held

68.4M

Call Options Held

226K

Put Options Held

285K

View Full List

About ARVINAS, INC.

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $1.2B
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

More about ARVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account